ArticlemAbs2016

Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab.

Fabienne Courtois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.